A detailed history of Sjs Investment Consulting Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 11 shares of PTCT stock, worth $384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 7 57.14%
Holding current value
$384
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$24.69 - $40.12 $98 - $160
4 Added 57.14%
11 $0
Q4 2023

Jan 16, 2024

BUY
$18.07 - $29.37 $54 - $88
3 Added 75.0%
7 $0
Q3 2023

Oct 17, 2023

SELL
$22.41 - $41.99 $44 - $83
-2 Reduced 33.33%
4 $0
Q1 2023

Apr 20, 2023

BUY
$38.16 - $48.86 $152 - $195
4 Added 200.0%
6 $0
Q4 2022

Jan 23, 2023

BUY
$33.53 - $54.79 $33 - $54
1 Added 100.0%
2 $0
Q3 2022

Oct 13, 2022

BUY
$41.85 - $53.85 $41 - $53
1 New
1 $0

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.5B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Sjs Investment Consulting Inc. Portfolio

Follow Sjs Investment Consulting Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sjs Investment Consulting Inc. with notifications on news.